Ozempic, Wegovy, Other Glp-1ra Drugs Not Linked To Increased Pancreatic Cancer Risk, Study Finds

Mobidoctor Podcast di Mobidoctor

05:37
Note sull'episodio

Ozempic, Wegovy, Other Glp-1ra Drugs Not Linked To Increased Pancreatic Cancer Risk, Study Finds

https://www.mobidoctor.eu/blog/ozempic-wegovy-other-glp-1ra-drugs-not-linked-to-increased-pancreatic-cancer-risk-study-finds

Parole chiave
Ozempic, Wegovy, Other Glp-1ra Drugs Not Linked To Increased Pancreatic Cancer Risk, Study Finds